<DOC>
	<DOCNO>NCT00767052</DOCNO>
	<brief_summary>The purpose study investigate safety , tolerability pharmacokinetics multiple ascend oral dos AZD1236 give healthy young subject 13 day evaluate single-dose relative bioavailability oral suspension oral tablet formulation .</brief_summary>
	<brief_title>Investigate Safety Tolerability Pharmacokinetics Multiple Doses AZD1236</brief_title>
	<detailed_description />
	<criteria>Provision sign informed consent prior study specific procedure Body Mass Index ( BMI ) 1927 kg/m2 Receipt another investigational drug 4 month dose study Acute illness require medical intervention within 2 week Visit 2 . Abnormal rest BP pulse rate ( rest 10 minute ) . Supine blood pressure &gt; 140 mmHg systolic &gt; 90 mmHg diastolic , pulse &lt; = 50 = &gt; 90 beat per minute</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Healthy Volunteer</keyword>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>AZD1236</keyword>
</DOC>